Trials / Completed
CompletedNCT00964769
Study of Evaluation Indexes for Antibody Production in Sera After Immunization
A Study of Evaluation Indexes for Antibody Production in Sera After Immunization
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Ewha Womans University · Academic / Other
- Sex
- All
- Age
- 2 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to evaluate analytical methods such as ELISA and OPKA that measure the activity of vaccine-induced pneumococcal antibodies. After validation of ELISA and OPKA, pneumococcal antibodies were measured by ELISA and OPKA in paired samples before and after immunization (pneumococcal PS vaccine) in children, adults and elderly.
Detailed description
To evaluate the immune response to the pneumococcal polysaccharide vaccine in the elderly, samples from children, young adults and elderly were obtained before and one month after vaccination. The quantitative and qualitative response to the vaccine were measured by the ELISA and opsonophagocytic killing assay for eight vaccine type serotypes (4, 6B, 9V, 14, 18C, 19A, 19F, 23F) and one vaccine-related serotype (6A).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | pneumococcal polysaccharide vaccine | single intramuscular injection of 0.5 ml Pneumo23® (Sanofi-Aventis, Lyon France) |
Timeline
- Start date
- 2005-04-01
- Primary completion
- 2005-05-01
- Completion
- 2005-06-01
- First posted
- 2009-08-25
- Last updated
- 2009-08-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00964769. Inclusion in this directory is not an endorsement.